Along with the obvious hits to patient traffic and population health, the COVID-19 pandemic delivered a financial upending to U.S. healthcare. Is it over yet? 

Going by criteria set and applied by Money magazine, only two of America’s 6,000 or so hospitals deserve the title “best of the best.”

A grocery-delivery giant is partnering with a commercial provider of medical house calls to bring healthy meals to patients in their homes.

Next time you browse Amazon for a health-related product, don’t be surprised when you get prompted to consider consulting with a personal care team.

Boston Scientific Corp. is purchasing Axonics in a move the buyer says will allow it to pursue a ripe segment of the urology market. 

A pharmacy benefit management company founded less than five years ago is teaming up with a drug pricing disrupter that will mark its second birthday next month.

Over the past three years, the value of claims waiting longer than 90 days for payment from commercial payers has risen by 33%. Stalled Medicare Advantage claims have spiked by even more.

In its annual outlook report released this week, Fitch Ratings says the coming calendar year will probably strike much of the sector as “another make or break” period.